Vaccination for Human Papillomavirus: an historic and bibliometric study

Research trends and hotspots on human papillomavirus: a bibliometric analysis of 100 most-cited articles

“…In addition to women, the efficacy of the HPV vaccine against anal infection and neoplasia for men was also published in 2011 ( 33 ), which was coherent with the recent studies on anal cancer. The recommendation, acceptability, and barriers of HPV vaccination were also hot topics ( 34 - 36 ), which were also identified in the previous bibliometric study ( 13 ).…”

“…This is the first bibliometric analysis of the overall HPV research field. The other bibliometric study in the HPV field was published in 2021, focusing on the HPV vaccination ( 13 ). Our study aimed to reveal the current research hotspots and emerging trends of HPV research by evaluating the detailed information of the 100 most-cited articles closely related to HPV.…”

“…In the case of HPV, the implementation of vaccination has dramatically changed the focus of research. The recent bibliometric study on HPV concentrated on HPV vaccination and illustrated the exponential dynamics of the publications with clinical trials providing evidence of the efficacy and safety of the HPV vaccine ( 13 ). While vaccination is one of the most high-profile topics in the HPV field, other subjects such as HPV-related cancers, infection populations, and cervical cancer screening also dominate.…”

How can we use bibliometric analysis to guide research forward?—an editorial for “Research trends and hotspots on human papillomavirus: a bibliometric analysis of 100 most-cited articles”

“…Human papillomavirus (HPV) is the most common sexually transmitted infection, and between 70–80% of all people will be infected at least one time in life ( 1 , 2 ). With cervical cancer being one of the leading cancers in women substantial efforts have been focused on finding the aetiology.…”

“…Annually, 630,000 new cancer cases are estimated to derive from HPV-infections ( 6 ). The identification of the causal link between HPV and cervical cancer lead to improved screening for cervical cancer, increased treatment ability as a consequence hereof, and to the development of vaccines against HPV ( 2 ). Currently, three prophylactic vaccines against HPV are on the market; bivalent, quadrivalent and nonavalent.…”